Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trial.
Ross JE, Perumal R, Wolf A, Zulu M, Guzman K, Seepamore B, Reis K, Nyilana H, Hlathi S, Narasimmulu R, Cheung YKK, Amico KR, Friedland G, Daftary A, Zelnick J, Naidoo K, O'Donnell MR. Ross JE, et al. Among authors: amico kr. Res Sq [Preprint]. 2023 Jun 9:rs.3.rs-2841179. doi: 10.21203/rs.3.rs-2841179/v1. Res Sq. 2023. PMID: 37333087 Free PMC article. Updated. Preprint.
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infection.
Reis K, Wolf A, Perumal R, Seepamore B, Guzman K, Ross J, Cheung K, Amico KR, Brust JCM, Padayatchi N, Friedland G, Naidoo K, Daftary A, Zelnick J, O'Donnell M. Reis K, et al. Among authors: amico kr. J Acquir Immune Defic Syndr. 2024 Feb 6. doi: 10.1097/QAI.0000000000003394. Online ahead of print. J Acquir Immune Defic Syndr. 2024. PMID: 38323838
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial.
Ross J, Perumal R, Wolf A, Zulu M, Guzman K, Seepamore B, Reis K, Nyilana H, Hlathi S, Narasimmulu R, Cheung YKK, Amico KR, Friedland G, Daftary A, Zelnick JR, Naidoo K, O'Donnell MR. Ross J, et al. Among authors: amico kr. Trials. 2023 Dec 1;24(1):776. doi: 10.1186/s13063-023-07520-9. Trials. 2023. PMID: 38037105 Free PMC article.
A Patient-Centered, Combination Intervention to Support Adherence to HIV Pre-exposure Prophylaxis During Pregnancy and Breastfeeding: A Randomized Pilot Study in Malawi.
Chi BH, Saidi F, Graybill LA, Phanga T, Mollan KR, Amico KR, Freeborn K, Rosenberg NE, Hill LM, Hamoonga T, Richardson B, Kalua T, Phiri S, Mutale W. Chi BH, et al. Among authors: amico kr. J Acquir Immune Defic Syndr. 2024 Jan 1;95(1):42-51. doi: 10.1097/QAI.0000000000003309. J Acquir Immune Defic Syndr. 2024. PMID: 37757844 Clinical Trial.
Acceptability of a Combination Adherence Strategy to Support HIV Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence During Pregnancy and Breastfeeding in Malawi.
Saidi F, Phanga T, Graybill LA, Mollan KR, Hill LM, Sibande W, Msowoya G, Thom A, Rosenberg NE, Freeborn K, Amico KR, Phiri S, Mutale W, Chi BH. Saidi F, et al. Among authors: amico kr. AIDS Behav. 2023 Dec;27(12):4022-4032. doi: 10.1007/s10461-023-04116-x. Epub 2023 Jul 1. AIDS Behav. 2023. PMID: 37392270
206 results